ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
China Medical System Holdings Ltd (PK)

China Medical System Holdings Ltd (PK) (CHSYF)

1,5683
0,00
(0,00%)
Fermé 24 Juin 10:00PM

China Medical System Holdings Ltd (PK) (CHSYF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,5683
( - )
Prix Achat
1,5683
Prix Vente
1,5683
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,35 Plage de 52 semaines 1,6358
Cap du marché
Clôture Veille
1,5683
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 5 139 617
Actions en circulation
2 420 501 512
Rendement du Dividende (LTM)
0,29
Ratio Cours sur Bénéfices
14,58
Bénéfice par action (BPA)
0,62
Chiffre d'affairess (LTM)
8,21B
Bénéfice net (LTM)
1,49B

À propos de China Medical System Holdings Ltd (PK)

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam na... China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression. It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn’s disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones. In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne. Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
North Point, Hong Kong
Fondé
1995
China Medical System Holdings Ltd (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CHSYF. Le dernier cours de clôture d'China Medical System (PK) était de US$1,57. Au cours de la dernière année, les actions de China Medical System (PK) ont été négociées dans une fourchette de prix de US$ 1,35 à US$ 1,6358.

China Medical System (PK) compte actuellement 2 420 501 512 actions en circulation. La capitalisation boursière d'China Medical System (PK) est de US$3,80 milliard. China Medical System (PK) a un ratio cours/bénéfice (ratio PE) de 14.58.

CHSYF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.568251.568251.568253001.56825CS
4001.568251.568251.568253001.56825CS
120.2182516.16666666671.351.568251.35751.56825CS
260.2182516.16666666671.351.568251.35431.56825CS
52-0.06755-4.129477931291.63581.63581.355161.5328207CS
1560.050253.310276679841.5181.63580.93077081.23790194CS
260-0.88175-35.98979591842.452.450.9307115561.87900534CS

CHSYF - Frequently Asked Questions (FAQ)

What is the current China Medical System Holdings Ltd (PK) share price?
The current share price of China Medical System Holdings Ltd (PK) is US$ 1,5683
How many China Medical System Holdings Ltd (PK) shares are in issue?
China Medical System Holdings Ltd (PK) has 2 420 501 512 shares in issue
What is the market cap of China Medical System Holdings Ltd (PK)?
The market capitalisation of China Medical System Holdings Ltd (PK) is USD 3,8B
What is the 1 year trading range for China Medical System Holdings Ltd (PK) share price?
China Medical System Holdings Ltd (PK) has traded in the range of US$ 1,35 to US$ 1,6358 during the past year
What is the PE ratio of China Medical System Holdings Ltd (PK)?
The price to earnings ratio of China Medical System Holdings Ltd (PK) is 14,58
What is the cash to sales ratio of China Medical System Holdings Ltd (PK)?
The cash to sales ratio of China Medical System Holdings Ltd (PK) is 2,64
What is the registered address of China Medical System Holdings Ltd (PK)?
The registered address for China Medical System Holdings Ltd (PK) is Island Place Tower, North Point
What is the China Medical System Holdings Ltd (PK) website address?
The website address for China Medical System Holdings Ltd (PK) is web.cms.net.cn/zh/home/
Which industry sector does China Medical System Holdings Ltd (PK) operate in?
China Medical System Holdings Ltd (PK) operates in the Pharmaceuticals sector

CHSYF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock